Systematic review examines vision loss cases after nasal filler injections

A systematic review of 21 articles identified 22 reported cases of vision loss following nonsurgical rhinoplasty with dermal fillers, most commonly hyaluronic acid injected into the nasal bridge or dorsum. The review found that vision loss occurred immediately in 82% of cases and that full visual recovery occurred in only 27%, taking an average of 5.3 months, despite treatment with hyaluronidase, corticosteroids, and antibiotics. The authors noted hyperbaric oxygen therapy showed promise but warrants further study.

Most relevant for: Patients considering or undergoing nonsurgical rhinoplasty with dermal filler injections, particularly in the nasal bridge or glabellar region.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.